摘要
甲状腺微小乳头状癌(papillary thyroid microcarcinoma, PTMC)广义上指最大直径<10 mm的乳头状癌。随着检查技术及水平的提高,甲状腺癌的检出率逐渐增加,并且PTMC在甲状腺乳头状癌(papillary thyroid carcinoma, PTC)中的构成比越来越高。目前针对PTMC,尤其是低危PTMC的治疗决策争论不断,但是精准化、微创化、个体化的治疗方式是目前的发展趋势。
Papillary thyroid microcarcinoma(PTMC) is defined as the malignant tumor that the maximum diameter of the nodule<10 mm generally.With the development of technology and examination, the discovery rate of thyroid carcinoma is increasing.Besides, PTMC is accounting for more and more ratio in papillary thyroid carcinoma(PTC).Currently, the therapy of PTMC,especially low risk PTMC,is still controversial, but precised, minimally invasive and personalized treatment is the develpoing trend.
作者
逯泓智
陈宇
张广旭
张广
LU Hongzhi;CHEN Yu;ZHANG Guangxu;ZHANG Guang(Division of Thyroid Surgery,China-Japan Union Hospital of Jilin University,Jilin Provincial Key Laboratory of Surgical Translational Medicine,Jilin Provincial Engineering Laboratory for Thyroid Disease Control,Jilin Changchun 130033,China)
出处
《现代肿瘤医学》
CAS
北大核心
2022年第20期3799-3802,共4页
Journal of Modern Oncology
关键词
甲状腺微小乳头状癌
热消融
低危恶性肿瘤
papillary thyroid microcarcinoma
thermal ablation
low risk malignancy
作者简介
逯泓智(1993-),男,吉林吉林人,硕士研究生,主要从事甲状腺及甲状旁腺疾病临床研究。E-mail:951577102@qq.com;通讯作者:张广(1974-),男,吉林榆树人,主任医师,主要从事甲状腺及甲状旁腺临床与基础研究。E-mail:Zhangguang_74@163.com。
